Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Fallowfield

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
BMJ Nutrition, Prevention & Health|November 25, 2020
Misclassification of coffee consumption data and the development of a standardised coffee unit measureRobin Poole, Sean Ewings, Julie Parkes, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 19, 2024
Interpreting elevated liver blood test results through a genetic lens: A genome-wide association studyHamish Innes, Stephan Buch, Timothy J Kendall, et al.
Annals of Hepatology|July 6, 2024
Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health recordsIgnat Drozdov, Benjamin Szubert, Ian A Rowe, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 7, 2024
Outcome prediction in metabolic dysfunction-associated steatotic liver disease using stain-free digital pathological assessmentTimothy J Kendall, Elaine Chng, Yayun Ren, et al.
Nature Reviews. Gastroenterology & Hepatology|April 20, 2026
Deciphering cytochrome P450 reductase role in MASLD: molecular mechanisms and pathophysiological implicationsCatarina Baptista, Francisco Esteves, Jonathan A Fallowfield, et al.
Scientific Reports|September 18, 2020
A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosisAndrea Dennis, Sofia Mouchti, Matt Kelly, et al.
BMJ (Clinical Research Ed.)|November 24, 2017
Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomesRobin Poole, Oliver J Kennedy, Paul Roderick, et al.
BMC Public Health|June 22, 2021
All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank studyOliver J Kennedy, Jonathan A Fallowfield, Robin Poole, et al.
The Journal of Pathology. Clinical Research|June 2, 2021
Reliable computational quantification of liver fibrosis is compromised by inherent staining variationStuart Astbury, Jane I Grove, David A Dorward, et al.
Nature Reviews. Gastroenterology & Hepatology|June 2, 2023
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approachPaul N Brennan, Ahmed M Elsharkawy, Timothy J Kendall, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
BMJ Nutrition, Prevention & Health|November 25, 2020
Misclassification of coffee consumption data and the development of a standardised coffee unit measureRobin Poole, Sean Ewings, Julie Parkes, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 19, 2024
Interpreting elevated liver blood test results through a genetic lens: A genome-wide association studyHamish Innes, Stephan Buch, Timothy J Kendall, et al.
Annals of Hepatology|July 6, 2024
Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health recordsIgnat Drozdov, Benjamin Szubert, Ian A Rowe, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 7, 2024
Outcome prediction in metabolic dysfunction-associated steatotic liver disease using stain-free digital pathological assessmentTimothy J Kendall, Elaine Chng, Yayun Ren, et al.
Nature Reviews. Gastroenterology & Hepatology|April 20, 2026
Deciphering cytochrome P450 reductase role in MASLD: molecular mechanisms and pathophysiological implicationsCatarina Baptista, Francisco Esteves, Jonathan A Fallowfield, et al.
Scientific Reports|September 18, 2020
A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosisAndrea Dennis, Sofia Mouchti, Matt Kelly, et al.
BMJ (Clinical Research Ed.)|November 24, 2017
Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomesRobin Poole, Oliver J Kennedy, Paul Roderick, et al.
BMC Public Health|June 22, 2021
All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank studyOliver J Kennedy, Jonathan A Fallowfield, Robin Poole, et al.
The Journal of Pathology. Clinical Research|June 2, 2021
Reliable computational quantification of liver fibrosis is compromised by inherent staining variationStuart Astbury, Jane I Grove, David A Dorward, et al.
Nature Reviews. Gastroenterology & Hepatology|June 2, 2023
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approachPaul N Brennan, Ahmed M Elsharkawy, Timothy J Kendall, et al.
Pageof 7